Obesity induces both local and systemic changes implicated in breast cancer
progression. Obesity-induced systemic changes include increases in circulating
insulin and insulin-like growth factor–1 (IGF-1), which can act within
the breast microenvironment to promote cancer progression. Adipocytes in the
breast might contribute to breast tumor development through the increased
secretion of adipocyte-derived hormones and growth factors (adipokines),
including the hormone leptin and paracrine growth factor hepatocyte growth
factor (HGF), and the diminished secretion of adiponectin, which is a protein
involved in the regulation of glucose levels. Adipocytes also produce aromatase,
which can lead to increased local estrogen concentrations in the obese breast.
Adipocytes or recruited immune cells (including macrophages), which form
characteristic crownlike structures around adipocytes, secrete increased amounts
of multiple cytokines and other growth factors in breast adipose depot.
Unregulated growth of adipocytes under conditions of obesity also produces
hypoxic conditions, which may elevate localized angiogenesis. Now, Seo
et al. have identified an additional mechanism by which
increased collagen and fibronectin deposition within obese adipose tissue
contributes to ECM stiffness, which promotes breast tumor progression.